Boston Scientific, Bard Reach Distribution Agreement for Drug-Coated Balloon February 9, 2015 BSX will be allowed to distribute Bard’s Lutonix 035 in the U.S. Read More
Pfizer’s Ibrance Breast Cancer Drug Gets Accelerated Approval February 9, 2015 The FDA says the drug shows reasonable evidence of clinical benefit to warrant marketing it ahead of a Phase III study. Read More
India High Court Temporarily Halts Sovaldi Competition February 6, 2015 The Delhi high court set aside a government order rejecting Gilead’s patent for tis hepatitis C drug. Read More
Medtronic to Launch Aneurysm Treatment Device, Following FDA Approval February 6, 2015 The Pipeline Flex diverts blood flow away from large brain aneurysms. Read More
Columbia U. Researchers Develop Smartphone HIV, Syphilis Test February 5, 2015 The dongle plugs into a phone’s audio jack and replicates an ELISA assay. Read More
Valeant Offers $296 Million for Dendreon’s Prostate Cancer Drug Provenge February 5, 2015 The deal gives Valeant a much-desired entry into the oncology market. Read More
Medtronic’s Melody Transcatheter Pulmonary Valve Wins FDA Nod February 4, 2015 Previously available via a humanitarian device exemption, the device but showed safety and efficacy in new studies. Read More
European Regulators Approve GSK/Novartis Business Swap February 4, 2015 The complicated three-part transaction would see the firms trade parts of their companies and create a consumer healthcare joint venture. Read More
T2 Biosystems and Canon to Develop Rapid Lyme Disease Test February 3, 2015 The test could provide results in hours, instead of weeks for a blood culture. Read More
Pfizer Pays $400 Million to Settle Off-Label Shareholder Lawsuit February 3, 2015 The complaint was filed in 2010. Read More
FDA Gives Green Light to ev3’s Protégé GPS Self-Expanding Stent System February 2, 2015 The stent is for opening leg arteries that have narrowed due to formation of plaque. Read More
Supreme Court’s Copaxone Ruling Already Influencing Other Drug Patent Cases February 2, 2015 The court sent several patent cases, including one Hatch-Waxman dispute, back to the appellate level. Read More